TheEdgeResearch
Home / Stocks / EMOR

Healixa Inc (EMOR)

OTC Technology Software - Application
$0.04 ▲ +0.00%
Market Cap
$30.7M
Sector
Technology
Industry
Software - Application
Beta
0.17
52-Wk Range
0.01-0.07
CEO
Ian Parker
Country
US
Currency
USD

Healixa Inc operates in the Software - Application industry of the Technology sector, headquartered in Holbrook, NY, US. The stock last traded at $0.04, up 0.00% on the session, giving a market capitalisation of $30.7M. On trailing twelve-month figures it carries a trailing P/E of -80.00, a net margin of -177.9%. Its beta of 0.17 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-80.00
Price / Sales
63.48
Price / Book
-3.15
EV / EBITDA
-82.40
Gross margin
77.4%
Operating margin
-96.1%
Net margin
-177.9%
Return on equity
Debt / equity
-0.69
Current ratio
0.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
26
IPO date
2010-12-13
Headquarters
Holbrook, NY, US
About Healixa Inc

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa Inc. also operates digital pharmacy marketplace. The company was formerly known as Emerald Organic Products Inc. and changed its name to Healixa Inc. in April 2021. The company was founded in 1977 and is based in Holbrook, New York.

Comparable companies

Healixa Inc is most often compared with the following Technology names:

ALRTFBQSTHMTXFMDBIFOPGNPAXHPBSVSPLTFUDOCFVYND
More research on EMOR
EMOR technical analysis EMOR TheEdge Score Compare against peers
Open full interactive analysis & DCF →